Fact CheckerSign in

NCT04319328Completed

Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?

Pharmacokinetic Evaluation of Cefazolin, Ceftazidime, and Ciprofloxacin in Chronic Hemodialysis Patients

Source: ClinicalTrials.gov · Last updated 16 May 2024

Brief summary (registry, in English)

This study aims to optimize the dosing of cefazolin, ceftazidime, and ciprofloxacin for patients on high-flux hemodialysis. For each antibiotic 20 participants will be enrolled and three blood samples will be collected from each participant. Antibiotic levels will be measured in each blood sample. This data will be used to develop population-pharmacokinetic models for each antibiotic. Finally, Monte Carlo simulations will be used to develop evidence-based dosing recommendations.

Status (registry)
Completed
Study type
Observational
Enrollment
40 (actual)
First submitted
2 Mar 2020
Start date
18 Oct 2019
Primary completion date
30 Apr 2024
Lead sponsor
University of Manitoba
NCT number
NCT04319328

What you commit to

  • Study type: Observational
  • Participants enrolled: 40
  • From 18 Oct 2019 to the primary completion date, 30 Apr 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Received study drug as part of a different treatment course in 1-week preceding start of new treatment course

Other illness

  • Chronic liver disease, Child Pugh Class C or higher

Other

  • Acute kidney injury or recovering kidney function

Who the study is looking for

  • \>18 years old
  • Proven or suspected infection
  • Receiving cefazolin, ceftazidime, or ciprofloxacin for treatment
  • Treatment course allows for collection of three 6 mL blood samples as per protocol

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saint Boniface Hospital, Outpatient Hemodialysis Unit
Coordinator of this site? Confirm its status
WinnipegCanadaUnknown status
College of Pharmacy, University of Manitoba
Coordinator of this site? Confirm its status
WinnipegCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.